Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 241-260 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 241 | Skylo Technologies lowweak | Opp 2 Risk 3 | Thesis: Reviewed evidence membership rationale suggests Skylo is positioned in standards-based direct-to-device satellite connectivity and had planned rollout across 37+ countries, but no kept post-recent evidence window direct positive evidence or representative articles were available for ranking, so the opportunity case is mostly ungrounded in these reviewed sources. Why now: There is no fresh kept article evidence after the March 29, 2026 cutoff; timing support is weak and recency is effectively absent in the ranking payload. Caveats: No evidence were kept after recent evidence window for ranking. Membership rationale is not sufficient by itself for a strong directional thesis. |
| 242 | Space Forge lowweak | Opp 2 Risk 2 | Thesis: There may be some long-horizon opportunity from UK space-technology support and in-space manufacturing positioning, but these reviewed sources does not include kept citable evidence to substantiate a stronger thesis. Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation. Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty. |
| 243 | Space Mission Systems lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale notes article context around the Space Force's Andromeda contract and selected operating companies, which could imply some opportunity if this candidate were clearly identified. However, the reviewed sources explicitly says the candidate name is not clearly tied in the summary to a specific qualifying company, and there are no available direct evidence after recent evidence window. Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources. |
| 244 | Spacety lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale says Spacety is a Chinese satellite startup focused on SAR satellites and had raised substantial funding ahead of an IPO, which could indicate commercial ambition if still current. Why now: There is no dated evidence retained after recent evidence window for Spacety in these reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency is uncertain. Caveats: No representative articles or evidence are provided after recent evidence window. The only support is the phase2 membership rationale, which is weaker than direct event/fact evidence and does not provide /article summaries here. Because there is no in-window evidence, scores remain low on both axes. |
| 245 | SpinLaunch lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence context says SpinLaunch is developing a centrifugal satellite launcher, announced the Meridian Space broadband constellation, and selected Equinix for ground infrastructure, which could support a long-horizon platform build, but no within the recent evidence window direct evidence or cited article summaries are provided here. Why now: Why-now is weak because the reviewed sources show 0 evidence kept after the 90-day recent evidence window, so recency cannot be established from local evidence. Caveats: Phase2 membership rationale references and, but no article summaries or direct evidence are included, so they cannot be cited as factual support beyond noting the reviewed sources rationale. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score kept low because positive thesis is not directly grounded in usable article evidence in these reviewed sources. |
| 246 | Spire Global, Inc. lowweak | Opp 2 Risk 4 | Thesis: Spire’s reviewed sources context supports that it designs, builds, and operates its own satellite constellation and provides data services, but no reviewed evidence survived the 90-day recent evidence window for directional ranking, so there is no strong 'why now' opportunity case in these reviewed sources. Why now: There is no current catalyst in the kept ranking evidence. The only representative article provided is dated February 7, 2025, outside the recent evidence window, via at Caveats: Zero evidence were kept after the 90-day recent evidence window. The available article context is outside recent evidence window and should not be treated as current catalyst evidence. |
| 247 | SSC Space lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says SSC Space provides tracking and communications for Artemis II and Firefly's Blue Ghost mission and is investing in RF and optical ground stations, which would suggest durable infrastructure relevance over a 1 year+ horizon if supported by available evidence. However, these reviewed sources provide no within the recent evidence window evidence or article for ranking use. Why now: Why now is weak because no evidence survived into the ranking reviewed sources despite the membership rationale. Caveats: Phase-2 membership rationale references: but no or direct evidence row is available here. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Do not infer opportunity from mission association alone without available evidence. |
| 248 | Telesat Corporation lowweak | Opp 2 Risk 3 | Thesis: The membership rationale says Telesat Lightspeed is a satellite broadband constellation with first satellites planned in December 2026, which could matter over 1 year+, but the reviewed sources provide no within the recent evidence window direct evidence or article summaries to support a stronger opportunity score. Why now: No within the recent evidence window evidence were available for Telesat Corporation, so there is no current evidence-set-backed catalyst despite the membership rationale referencing future constellation timing. Caveats: Membership rationale references article IDs and, but their contents are not included here for direct citation. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. As a result, scores are necessarily conservative. |
| 249 | The ePlane Company lowweak | Opp 2 Risk 1 | Thesis: The ePlane Company has slight contextual upside because the membership rationale says it was listed among beneficiaries of India's spacetech/deeptech government RDI disbursal, which can be supportive for a 1 year+ strategic development thesis if confirmed with direct follow-through evidence (: unavailable in reviewed sources). However, no direct positive evidence are available in the reviewed sources. Why now: The government RDI disbursal reference could matter on a 1 year+ horizon, but the reviewed sources lack timestamps, and direct evidence, limiting confidence in timing and materiality. Caveats: No current evidence is provided for Government support mention is contextual and not enough alone to prove commercial traction. Zero evidence available after recent evidence window. |
| 250 | True Anomaly lowweak | Opp 2 Risk 1 | Thesis: True Anomaly has a slightly higher opportunity score than the no-evidence names because the membership rationale references a $650M raise, Jackal spacecraft work, and the Space Force Victus Haze mission, which would matter over a 1 year+ horizon if substantiated. However, no available within the recent evidence window evidence or article summaries are provided in these reviewed sources. Why now: Why-now is weak because the cited raise and mission activity appear only in membership rationale, without scoreable dated article details in the current evidence set. Caveats: Membership rationale cites, and, but the supporting articles are not available for direct use. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. A positive thesis requires positive evidence; membership rationale alone only supports a modest watchlist bias. |
| 251 | Ulook lowweak | Opp 2 Risk 3 | Thesis: Limited evidence-ranked opportunity: the reviewed sources membership rationale says Ulook plans RF ELINT/RF detection satellites by 2027 and appears in Indian space startup launch manifests, which implies product ambition and some ecosystem visibility, but no direct positive evidence or article summaries were available within the recent evidence window. Why now: Why now is weak because the reviewed sources show two articles were considered for membership support, yet zero article context or evidence were available after recent evidence window; recency and milestone timing are therefore uncertain. The membership rationale references article IDs and, but no or article dates were provided in the reviewed sources. Caveats: No direct positive or negative evidence were provided after recent evidence window. Membership rationale references article IDs and, but no are available, so those claims cannot be fully cited under the the evidence standard. Opportunity score is kept low because membership is not thesis attractiveness. |
| 252 | United Launch Alliance lowweak | Opp 2 Risk 2 | Thesis: The membership rationale confirms ULA remains in launch operations and competition context, but the reviewed sources provide no available within the recent evidence window direct event or fact evidence to support a stronger opportunity thesis. Why now: The membership rationale cites articles: and: but no article summaries or evidence are available after recent evidence filtering for ranking. Caveats: Launch-industry membership is not itself a directional thesis. Coverage debug shows zero evidence after recent evidence window despite many considered articles. No direct contract, launch cadence, backlog, or failure evidence is available in these reviewed sources. |
| 253 | Voyager Technologies Inc. lowweak | Opp 2 Risk 2 | Thesis: A mild opportunity prior exists only because phase-2 rationale says Voyager is a space infrastructure company with backlog growth and a DARPA-related subcontract, but this cannot be elevated because no retained within the recent evidence window evidence or citable article summaries are included in the reviewed sources. Why now: There is no citable within the recent evidence window evidence in the reviewed sources to justify a strong 1 year+ 'why now' despite broad historical article coverage. Caveats: Phase-2 rationale references: and: but no or summaries are provided here. Coverage debug shows 78 articles considered but 0 article IDs after recent evidence window and 0 available evidence. Ticker ambiguity exists in aliases (VOYG, VYGR), but the required output ticker is VOYG. |
| 254 | VSBLTY Groupe Technologies Corp. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says VSBLTY signed an LOI related to integrated AI and sovereign satellite infrastructure in the Philippines, suggesting possible adjacent upside if such positioning becomes commercially meaningful, but there is no available direct evidence, quote, or to substantiate a positive thesis. Why now: No reviewed sources-grounded timing support is available for why this matters now over a 1 year+ horizon; the reviewed sources retains zero evidence after the cutoff and provides no citable for article. Caveats: Reviewed evidence is limited to a membership rationale; there are no representative article summaries, or evidence after recent evidence window. The cited article id is not accompanied by a in the reviewed sources, so it cannot be used for factual claim citation. Slightly higher opportunity/risk than some peers reflects adjacency language in the reviewed sources rationale only, not strong direct evidence. |
| 255 | Windward lowweak | Opp 2 Risk 1 | Thesis: Windward appears to have direct involvement in maritime domain awareness using integrated space-based monitoring per the reviewed sources rationale, which suggests some space-data leverage, but the reviewed sources does not establish it as a space domain awareness company and offers no retained direct evidence, so opportunity is only marginal. Why now: There is no validated within the recent evidence window catalyst. The only support cited is phase-2 rationale referencing, and without or retained evidence. Caveats: Reviewed evidence language distinguishes maritime domain awareness from space domain awareness. No retained article summaries or evidence are available after recent evidence window. Context-only relations must not be propagated into stronger thesis claims. |
| 256 | Xdlinx lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale says Xdlinx appeared in a launch manifest with multiple 2026 missions including a quantum key distribution satellite and was listed among Indian space startups with satellite buses, but none of that is retained as in-window evidence here. Why now: The reviewed sources includes no representative article or retained evidence within the 90-day recent evidence window, so recency and current status are uncertain for Xdlinx in this screen. Caveats: No retained evidence after recent evidence window. Phase-2 membership support alone is not enough for a stronger score. |
| 257 | XDLINX Space Labs lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources' membership rationale says an article identified XDLINX Space Labs as the highest-revenue company among an Indian space-tech startup sample via article: which is directionally encouraging, but no retained direct in-window evidence with is available. Why now: No current catalyst is evidenced; coverage after recent evidence window is empty. Caveats: Reviewed evidence mentions: but provides no. Higher-revenue claim is only from membership rationale and may not be current. No retained structured positive or negative evidence after recent evidence window. |
| 258 | Zoove Space lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources say Zoove Space was selected for a spacetech accelerator, which is a mild positive signal for ecosystem validation and support, but the evidence is too sparse to rank it as a strong opportunity. Why now: The reviewed sources offers no in-window evidence to confirm timing beyond the phase-2 rationale, so the current catalyst strength is limited. Caveats: No evidence remained after the 90-day recent evidence window. Accelerator selection is a weak signal relative to financing, contracts, or operating milestones. No direct dated article is available in the reviewed sources body. |
| 259 | ADAspace lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources rationale says ADAspace launched a space computing cloud service platform, but no within the recent evidence window direct evidence or citable article are provided in the reviewed sources output, so that does not support a strong opportunity thesis here. Why now: There is no usable within the recent evidence window evidence in the reviewed sources; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for ADAspace. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. No direct positive or negative evidence survived the 90-day recent evidence window. |
| 260 | AEVEX Corp. lowweak | Opp 1 Risk 1 | Thesis: AEVEX is only described as being mentioned in a space-focused SPAC and sector activity article, which is inadequate for a company-specific positive thesis. Why now: There is no reviewed sources-grounded catalyst or timing support for a 1 year+ thesis. The reviewed sources references article id: but provides no, quote, or retained evidence row. Caveats: Sector/SPAC mention is supporting article context and weaker than direct company-specific events or facts. No representative article summary or is present for direct citation. Low scores reflect sparse evidence, not a strong directional view. |
Risk view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Interlune lowweak | Opp 5 Risk 3 | Thesis: The company also carries execution risk because the reviewed sources provide no further retained evidence on milestone completion, follow-on awards, commercialization timing, or technical results. A single contract supports relevance but does not prove scalable economics. Why now: The key 'why now' is the cited NASA contract in article: but the reviewed sources does not include the article summary or, so exact date and latest status are not visible here. Caveats: Opportunity case relies on membership rationale rather than included direct article evidence. A $6.9M contract is positive validation, but contract size alone may not be enough to de-risk a lunar-resource business. No negative evidence is provided, so risk mostly reflects execution uncertainty. |
| 82 | IonQ lowweak | Opp 3 Risk 3 | Thesis: Risk stems from thesis leakage: the reviewed sources frames IonQ primarily as parent/acquirer, while the strongest space-specific evidence appears to sit at subsidiary level, so investors could overstate IonQ's direct space-business impact based on insufficient company-specific proof. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 83 | Iridium Communications Inc. lowmedium | Opp 5 Risk 3 | Thesis: Risk is moderate-low because there is no direct adverse evidence, but the reviewed sources lack recent company-specific contract, financing, or product milestone catalysts, so the case depends more on strategic position than on fresh business acceleration. Why now: The current support is an April 3, 2026 article-level overview of Iridium’s constellation and service footprint rather than a new event, so timing fit is only medium. Evidence
Caveats: Evidence is supporting article context, not a fresh contract or earnings-linked milestone. |
| 84 | Kepler mediummedium | Opp 6 Risk 3 | Thesis: Risk remains moderate because the evidence is primarily a company-source article and supporting article context rather than independent dated event evidence. The reviewed sources show no adverse developments, but also limited third-party confirmation. Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement. Evidence
Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation. |
| 85 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: There is no direct negative evidence available. The main risk is that the business description is broad but unsupported by current, citable post-recent evidence window evidence, leaving commercialization and scale uncertain. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 86 | L3Harris Technologies mediummedium | Opp 6 Risk 3 | Thesis: Risk is lower than many peers in these reviewed sources because there is no cited direct adverse evidence, but the ranking is capped by limited fresh company-specific evidence within the 90-day window and reliance on supporting article context rather than detailed award economics attributable specifically to L3Harris. Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context. Evidence
Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'. |
| 87 | Loft Orbital mediummedium | Opp 7 Risk 3 | Thesis: Risk exists because the positive case is largely supporting article context from external supporting source sources rather than direct dated events in the reviewed sources, and execution remains significant given a 10-satellite constellation deployment and launch timeline. But there is no retained material adverse evidence. Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'. Evidence
Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing. |
| 88 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because the available evidence is entirely undated external article context, making recency and state-of-business uncertain. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 89 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Risk remains moderate because the reviewed sources supplies no available positive evidence after recent evidence window to confirm timing, contract status, or deployment progress; mission-heavy lunar communications programs can be timing-sensitive, but these reviewed sources gives no adverse proof either. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 90 | Muon Space lowweak | Opp 3 Risk 3 | Thesis: Risk is balanced with opportunity because the available evidence is mostly weak supporting article context rather than direct contract, financing, or milestone evidence, leaving business traction and near-medium term scaling uncertain. Why now: The most recent dated context is a May 22, 2026 job posting indicating contracting and legal operations needs, which may imply organizational buildout but is weak evidence for a major catalyst. Evidence
Caveats: The reviewed sources contain no direct positive or negative company-specific events. The May 22, 2026 job posting is operational context, not proof of revenue or contracts. Citation |
| 91 | NordSpace Corp. lowweak | Opp 3 Risk 3 | Thesis: No direct adverse evidence is available, but development-stage rocket businesses carry obvious execution dependency; in these reviewed sources that risk cannot be upgraded to high because the evidence does not show a specific setback, only insufficient current confirmation. Why now: The only directional clue is the membership-support article reference: but the reviewed sources includes no, no summary, and no available post-recent evidence window evidence, so timing and durability are uncertain. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Opportunity case relies on generic funding support mention without current milestone evidence. |
| 92 | Northrop Grumman Corp mediumstrong | Opp 8 Risk 3 | Thesis: Risk is present but comparatively modest in the reviewed sources because no material adverse event is cited. The main risk is that the evidence is largely supporting article context and program participation, so exact economic contribution, timing, and competitive share are not fully established here. Why now: The setup is current and cumulative: April 8, 2026 Andromeda participation, June 1, 2026 Golden Dome interceptor partnership, and June 22, 2026 award of a $398M protected satcom contract all fall within the 90-day recent evidence window and point to sustained momentum. Evidence
Caveats: The reviewed sources does not provide direct business impact breakdowns beyond the $398M contract article. Some support is supporting article context rather than dated events. |
| 93 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because evidence coverage is very thin, and the reviewed sources offers mainly context that the company planned to go public via SPAC, without stronger direct proof on operational milestones or contract conversion in this company row. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 94 | Open Cosmos mediummedium | Opp 7 Risk 3 | Thesis: Risk is present but not strongly evidenced as negative news. The main risks are that the evidence is supporting article context rather than direct events, and one supporting item concerns spacecraft supply to a military mission rather than direct revenue or contract award to Open Cosmos. Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries. Evidence
Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation. |
| 95 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Risk is also meaningful because the same article describes an early-stage startup with only a $5 million pre-seed raise pursuing an extremely ambitious plan involving an in-orbit demo next year and more than 100,000 orbital data centers, which raises execution and scale risk, although this is supporting article context rather than direct adverse evidence, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
| 96 | Orbital Recovery Crew lowweak | Opp 3 Risk 3 | Thesis: Risk is also material because the evidence is limited to the company's own site and supporting article context, with no independent retained event evidence for contracts, missions, financing, customers, or regulatory outcomes; the same page also conditions service availability on manifest availability and continuing cooperation of regulatory bodies. Why now: The only retained evidence is a page with May 21, 2026, within the 90-day window, indicating recent discoverable claims of operations and service scope, but not a third-party validated catalyst. Evidence
Caveats: Evidence is company-site article context, not independent confirmation. No direct positive or negative dated events are available. Same-article repeated rows are not independent confirmation. |
| 97 | Overview Energy lowweak | Opp 4 Risk 3 | Thesis: The technology area appears highly ambitious and execution-sensitive, but no direct negative evidence is provided in the reviewed sources. Why now: The likely catalyst is the reported Air Force contract, yet the reviewed sources gives no retained article summary or evidence row to establish recency or contract scale. Caveats: Phase2 membership rationale references: but no article summary or evidence are available. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 98 | Pacific Defense lowweak | Opp 4 Risk 3 | Thesis: Despite the favorable context, the reviewed sources contain no post-recent evidence window evidence, no -backed article summary, and no fresh proof of follow-on contracts or operational success after the demo; that limits conviction and leaves execution risk unresolved. Why now: The company appears more advanced than several peers because the reviewed sources references an on-orbit demo under contract, but there is no citable recency signal beyond membership support article ID: and no available evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary for citation. Opportunity score is relative within a weak-evidence batch, not high absolute conviction. |
| 99 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Main risk is evidence opacity and recency uncertainty rather than documented adverse events. The reviewed sources show one article considered but zero article IDs after recent evidence window and zero evidence available after recent evidence window, so business-state visibility is poor. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 100 | Planet Labs PBC lowweak | Opp 3 Risk 3 | Thesis: Risk is moderate because the reviewed sources lack recent direct evidence on contracts, growth, financing, or setbacks, leaving the current business trajectory uncertain. Why now: Why-now is weak: the only in-window evidence is an April 5, 2026 startup-listing article describing Planet as operating its own satellite constellation and geospatial analytics platform, which is durable context but not a clear catalyst. Evidence
Caveats: Evidence is only supporting article context, not direct company event or fact evidence with strong materiality. No direct positive or negative dated events are available. This is a low-conviction watchlist name in these reviewed sources. |